1	The	the	_	_	_	_	_	_	_
2	interleukin-8	interleukin-8	_	_	_	_	_	_	_
3	AP-1	ap-1	_	_	_	_	_	_	_
4	and	and	_	_	_	_	_	_	_
5	kappa	kappa	_	_	_	_	_	_	_
6	B-like	b-like	_	_	_	_	_	_	_
7	sites	site	_	_	_	_	_	_	_
8	are	be	_	_	_	_	_	_	_
9	genetic	genetic	_	_	_	_	_	_	_
10	end	end	_	_	_	_	_	_	_
11	targets	target	_	_	_	_	_	_	_
12	of	of	_	_	_	_	_	_	_
13	FK506-sensitive	fk506-sensitive	_	_	_	_	_	_	_
14	pathway	pathway	_	_	_	_	_	_	_
15	accompanied	accompany	_	_	_	_	_	_	_
16	by	by	_	_	_	_	_	_	_
17	calcium	calcium	_	_	_	_	_	_	_
18	mobilization	mobilization	_	_	_	_	_	_	_
19	.	.	_	_	_	_	_	_	_

1	FK506	FK506	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	an	an	_	_	_	_	_	_	_
4	immunosuppressant	immunosuppressant	_	_	_	_	_	_	_
5	,	,	_	_	_	_	_	_	_
6	inhibits	inhibit	_	_	_	_	_	_	_
7	the	the	_	_	_	_	_	_	_
8	production	production	_	_	_	_	_	_	_
9	of	of	_	_	_	_	_	_	_
10	several	several	_	_	_	_	_	_	_
11	cytokines	cytokine	_	_	_	_	_	_	_
12	in	in	_	_	_	_	_	_	_
13	T	t	_	_	_	_	_	_	_
14	lymphocytes	lymphocyte	_	_	_	_	_	_	_
15	.	.	_	_	_	_	_	_	_

1	We	we	_	_	_	_	_	_	_
2	observed	observe	_	_	_	_	_	_	_
3	that	that	_	_	_	_	_	_	_
4	FK506	FK506	_	_	_	_	_	_	_
5	suppressed	suppress	_	_	_	_	_	_	_
6	the	the	_	_	_	_	_	_	_
7	transcription	transcription	_	_	_	_	_	_	_
8	of	of	_	_	_	_	_	_	_
9	a	a	_	_	_	_	_	_	_
10	chemotactic	chemotactic	_	_	_	_	_	_	_
11	cytokine	cytokine	_	_	_	_	_	_	_
12	,	,	_	_	_	_	_	_	_
13	interleukin-8	interleukin-8	_	_	_	_	_	_	_
14	(	(	_	_	_	_	_	_	_
15	IL-8	il-8	_	_	_	_	_	_	_
16	)	)	_	_	_	_	_	_	_
17	in	in	_	_	_	_	_	_	_
18	a	a	_	_	_	_	_	_	_
19	human	human	_	_	_	_	_	_	_
20	T	t	_	_	_	_	_	_	_
21	cell	cell	_	_	_	_	_	_	_
22	line	line	_	_	_	_	_	_	_
23	,	,	_	_	_	_	_	_	_
24	Jurkat	Jurkat	_	_	_	_	_	_	_
25	cells	cell	_	_	_	_	_	_	_
26	,	,	_	_	_	_	_	_	_
27	activated	activate	_	_	_	_	_	_	_
28	by	by	_	_	_	_	_	_	_
29	phorbol	phorbol	_	_	_	_	_	_	_
30	12-myristate	12-myristate	_	_	_	_	_	_	_
31	13-acetate	13-acetate	_	_	_	_	_	_	_
32	(	(	_	_	_	_	_	_	_
33	PMA	PMA	_	_	_	_	_	_	_
34	)	)	_	_	_	_	_	_	_
35	and	and	_	_	_	_	_	_	_
36	calcium	calcium	_	_	_	_	_	_	_
37	(	(	_	_	_	_	_	_	_
38	Ca2+	Ca2+	_	_	_	_	_	_	_
39	)	)	_	_	_	_	_	_	_
40	ionophore	ionophore	_	_	_	_	_	_	_
41	(	(	_	_	_	_	_	_	_
42	ionomycin	ionomycin	_	_	_	_	_	_	_
43	)	)	_	_	_	_	_	_	_
44	.	.	_	_	_	_	_	_	_

1	By	by	_	_	_	_	_	_	_
2	deleted	delete	_	_	_	_	_	_	_
3	and	and	_	_	_	_	_	_	_
4	mutated	mutate	_	_	_	_	_	_	_
5	analysis	analysis	_	_	_	_	_	_	_
6	of	of	_	_	_	_	_	_	_
7	the	the	_	_	_	_	_	_	_
8	IL-8	il-8	_	_	_	_	_	_	_
9	promoters	promoter	_	_	_	_	_	_	_
10	,	,	_	_	_	_	_	_	_
11	the	the	_	_	_	_	_	_	_
12	AP-1	ap-1	_	_	_	_	_	_	_
13	and	and	_	_	_	_	_	_	_
14	kappa	kappa	_	_	_	_	_	_	_
15	B-like	b-like	_	_	_	_	_	_	_
16	sites	site	_	_	_	_	_	_	_
17	were	be	_	_	_	_	_	_	_
18	identified	identify	_	_	_	_	_	_	_
19	as	as	_	_	_	_	_	_	_
20	the	the	_	_	_	_	_	_	_
21	responsive	responsive	_	_	_	_	_	_	_
22	elements	element	_	_	_	_	_	_	_
23	for	for	_	_	_	_	_	_	_
24	PMA	PMA	_	_	_	_	_	_	_
25	and	and	_	_	_	_	_	_	_
26	ionomycin	ionomycin	_	_	_	_	_	_	_
27	.	.	_	_	_	_	_	_	_

1	FK506	FK506	_	_	_	_	_	_	_
2	suppressed	suppress	_	_	_	_	_	_	_
3	the	the	_	_	_	_	_	_	_
4	transcriptions	transcription	_	_	_	_	_	_	_
5	through	through	_	_	_	_	_	_	_
6	the	the	_	_	_	_	_	_	_
7	AP-1	ap-1	_	_	_	_	_	_	_
8	or	or	_	_	_	_	_	_	_
9	kappa	kappa	_	_	_	_	_	_	_
10	B-like	b-like	_	_	_	_	_	_	_
11	sites	site	_	_	_	_	_	_	_
12	induced	induce	_	_	_	_	_	_	_
13	by	by	_	_	_	_	_	_	_
14	PMA	PMA	_	_	_	_	_	_	_
15	plus	plus	_	_	_	_	_	_	_
16	Ca(2+)-mobilizing	ca(2+)-mobilizing	_	_	_	_	_	_	_
17	agents	agent	_	_	_	_	_	_	_
18	,	,	_	_	_	_	_	_	_
19	but	but	_	_	_	_	_	_	_
20	not	not	_	_	_	_	_	_	_
21	those	those	_	_	_	_	_	_	_
22	induced	induce	_	_	_	_	_	_	_
23	by	by	_	_	_	_	_	_	_
24	Ca(2+)-independent	ca(2+)-independent	_	_	_	_	_	_	_
25	stimuli	stimulus	_	_	_	_	_	_	_
26	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	gel	gel	_	_	_	_	_	_	_
3	retardation	retardation	_	_	_	_	_	_	_
4	analysis	analysis	_	_	_	_	_	_	_
5	,	,	_	_	_	_	_	_	_
6	FK506	FK506	_	_	_	_	_	_	_
7	had	have	_	_	_	_	_	_	_
8	little	little	_	_	_	_	_	_	_
9	effect	effect	_	_	_	_	_	_	_
10	on	on	_	_	_	_	_	_	_
11	the	the	_	_	_	_	_	_	_
12	binding	binding	_	_	_	_	_	_	_
13	to	to	_	_	_	_	_	_	_
14	the	the	_	_	_	_	_	_	_
15	AP-1	ap-1	_	_	_	_	_	_	_
16	site	site	_	_	_	_	_	_	_
17	of	of	_	_	_	_	_	_	_
18	PMA/ionomycin-induced	pma/ionomycin-induced	_	_	_	_	_	_	_
19	nuclear	nuclear	_	_	_	_	_	_	_
20	factors	factor	_	_	_	_	_	_	_
21	,	,	_	_	_	_	_	_	_
22	which	which	_	_	_	_	_	_	_
23	were	be	_	_	_	_	_	_	_
24	recognized	recognize	_	_	_	_	_	_	_
25	with	with	_	_	_	_	_	_	_
26	anti-JunD	anti-jund	_	_	_	_	_	_	_
27	or	or	_	_	_	_	_	_	_
28	c-Fos	c-fos	_	_	_	_	_	_	_
29	antibody	antibody	_	_	_	_	_	_	_
30	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	contrast	contrast	_	_	_	_	_	_	_
3	,	,	_	_	_	_	_	_	_
4	FK506	FK506	_	_	_	_	_	_	_
5	or	or	_	_	_	_	_	_	_
6	EGTA	EGTA	_	_	_	_	_	_	_
7	(	(	_	_	_	_	_	_	_
8	Ca2+	Ca2+	_	_	_	_	_	_	_
9	chelator	chelator	_	_	_	_	_	_	_
10	)	)	_	_	_	_	_	_	_
11	similarly	similarly	_	_	_	_	_	_	_
12	affected	affect	_	_	_	_	_	_	_
13	the	the	_	_	_	_	_	_	_
14	formation	formation	_	_	_	_	_	_	_
15	of	of	_	_	_	_	_	_	_
16	kappa	kappa	_	_	_	_	_	_	_
17	B-like	b-like	_	_	_	_	_	_	_
18	site	site	_	_	_	_	_	_	_
19	binding	binding	_	_	_	_	_	_	_
20	complexes	complex	_	_	_	_	_	_	_
21	,	,	_	_	_	_	_	_	_
22	which	which	_	_	_	_	_	_	_
23	were	be	_	_	_	_	_	_	_
24	not	not	_	_	_	_	_	_	_
25	recognized	recognize	_	_	_	_	_	_	_
26	by	by	_	_	_	_	_	_	_
27	any	any	_	_	_	_	_	_	_
28	antibodies	antibody	_	_	_	_	_	_	_
29	against	against	_	_	_	_	_	_	_
30	the	the	_	_	_	_	_	_	_
31	human	human	_	_	_	_	_	_	_
32	Rel	Rel	_	_	_	_	_	_	_
33	family	family	_	_	_	_	_	_	_
34	proteins	protein	_	_	_	_	_	_	_
35	(	(	_	_	_	_	_	_	_
36	c-Rel	c-rel	_	_	_	_	_	_	_
37	,	,	_	_	_	_	_	_	_
38	p65	p65	_	_	_	_	_	_	_
39	,	,	_	_	_	_	_	_	_
40	p50	p50	_	_	_	_	_	_	_
41	,	,	_	_	_	_	_	_	_
42	and	and	_	_	_	_	_	_	_
43	p49	p49	_	_	_	_	_	_	_
44	)	)	_	_	_	_	_	_	_
45	.	.	_	_	_	_	_	_	_

1	Furthermore	furthermore	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	we	we	_	_	_	_	_	_	_
4	confirmed	confirm	_	_	_	_	_	_	_
5	the	the	_	_	_	_	_	_	_
6	previous	previous	_	_	_	_	_	_	_
7	report	report	_	_	_	_	_	_	_
8	that	that	_	_	_	_	_	_	_
9	FK506	FK506	_	_	_	_	_	_	_
10	suppressed	suppress	_	_	_	_	_	_	_
11	the	the	_	_	_	_	_	_	_
12	PMA/ionomycin-induced	pma/ionomycin-induced	_	_	_	_	_	_	_
13	activation	activation	_	_	_	_	_	_	_
14	through	through	_	_	_	_	_	_	_
15	authentic	authentic	_	_	_	_	_	_	_
16	kappa	kappa	_	_	_	_	_	_	_
17	B	B	_	_	_	_	_	_	_
18	site	site	_	_	_	_	_	_	_
19	of	of	_	_	_	_	_	_	_
20	immunoglobulin	immunoglobulin	_	_	_	_	_	_	_
21	(	(	_	_	_	_	_	_	_
22	Ig	ig	_	_	_	_	_	_	_
23	)	)	_	_	_	_	_	_	_
24	gene	gene	_	_	_	_	_	_	_
25	,	,	_	_	_	_	_	_	_
26	to	to	_	_	_	_	_	_	_
27	which	which	_	_	_	_	_	_	_
28	NF-kappa	NF-kappa	_	_	_	_	_	_	_
29	B	B	_	_	_	_	_	_	_
30	binding	binding	_	_	_	_	_	_	_
31	was	be	_	_	_	_	_	_	_
32	also	also	_	_	_	_	_	_	_
33	decreased	decrease	_	_	_	_	_	_	_
34	by	by	_	_	_	_	_	_	_
35	FK506	FK506	_	_	_	_	_	_	_
36	,	,	_	_	_	_	_	_	_
37	indicating	indicate	_	_	_	_	_	_	_
38	that	that	_	_	_	_	_	_	_
39	both	both	_	_	_	_	_	_	_
40	IL-8	il-8	_	_	_	_	_	_	_
41	kappa	kappa	_	_	_	_	_	_	_
42	B-like	b-like	_	_	_	_	_	_	_
43	site	site	_	_	_	_	_	_	_
44	and	and	_	_	_	_	_	_	_
45	Ig	ig	_	_	_	_	_	_	_
46	kappa	kappa	_	_	_	_	_	_	_
47	B	B	_	_	_	_	_	_	_
48	site	site	_	_	_	_	_	_	_
49	are	be	_	_	_	_	_	_	_
50	FK506-sensitive	fk506-sensitive	_	_	_	_	_	_	_
51	in	in	_	_	_	_	_	_	_
52	spite	spite	_	_	_	_	_	_	_
53	of	of	_	_	_	_	_	_	_
54	the	the	_	_	_	_	_	_	_
55	difference	difference	_	_	_	_	_	_	_
56	of	of	_	_	_	_	_	_	_
57	binding	bind	_	_	_	_	_	_	_
58	factors	factor	_	_	_	_	_	_	_
59	.	.	_	_	_	_	_	_	_

1	Our	our	_	_	_	_	_	_	_
2	results	result	_	_	_	_	_	_	_
3	indicate	indicate	_	_	_	_	_	_	_
4	that	that	_	_	_	_	_	_	_
5	not	not	_	_	_	_	_	_	_
6	only	only	_	_	_	_	_	_	_
7	the	the	_	_	_	_	_	_	_
8	reported	report	_	_	_	_	_	_	_
9	IL-2	IL-2	_	_	_	_	_	_	_
10	NF-AT	NF-AT	_	_	_	_	_	_	_
11	and	and	_	_	_	_	_	_	_
12	NFIL-2A	NFIL-2A	_	_	_	_	_	_	_
13	sites	site	_	_	_	_	_	_	_
14	and	and	_	_	_	_	_	_	_
15	Ig	ig	_	_	_	_	_	_	_
16	kappa	kappa	_	_	_	_	_	_	_
17	B	B	_	_	_	_	_	_	_
18	site	site	_	_	_	_	_	_	_
19	,	,	_	_	_	_	_	_	_
20	but	but	_	_	_	_	_	_	_
21	also	also	_	_	_	_	_	_	_
22	the	the	_	_	_	_	_	_	_
23	IL-8	il-8	_	_	_	_	_	_	_
24	AP-1	ap-1	_	_	_	_	_	_	_
25	and	and	_	_	_	_	_	_	_
26	kappa	kappa	_	_	_	_	_	_	_
27	B-like	b-like	_	_	_	_	_	_	_
28	sites	site	_	_	_	_	_	_	_
29	are	be	_	_	_	_	_	_	_
30	terminals	terminal	_	_	_	_	_	_	_
31	of	of	_	_	_	_	_	_	_
32	FK506-sensitive	fk506-sensitive	_	_	_	_	_	_	_
33	pathway	pathway	_	_	_	_	_	_	_
34	involving	involve	_	_	_	_	_	_	_
35	Ca2+	ca2+	_	_	_	_	_	_	_
36	mobilization	mobilization	_	_	_	_	_	_	_
37	.	.	_	_	_	_	_	_	_

